Drug Shortage Report for INNOHEP
| Report ID | 88440 |
| Drug Identification Number | 02358174 |
| Brand name | INNOHEP |
| Common or Proper name | Tinzaparin sodium |
| Company Name | LEO PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | TINZAPARIN SODIUM |
| Strength(s) | 20000UNIT |
| Dosage form(s) | SOLUTION |
| Route of administration | SUBCUTANEOUS |
| Packaging size | 10 x 0.7mL syringe |
| ATC code | B01AB |
| ATC description | ANTITHROMBOTIC AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2019-07-04 |
| Actual start date | 2019-07-04 |
| Estimated end date | |
| Actual end date | 2019-10-24 |
| Shortage status | Resolved |
| Updated date | 2019-10-24 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6 ADELAIDE STREET EAST, SUITE 200 TORONTO, ONTARIO CANADA M5C 1H6 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v9 | 2019-10-24 | French | Compare |
| v8 | 2019-10-24 | English | Compare |
| v7 | 2019-10-10 | French | Compare |
| v6 | 2019-10-10 | English | Compare |
| v5 | 2019-07-29 | French | Compare |
| v4 | 2019-07-29 | English | Compare |
| v3 | 2019-07-05 | English | Compare |
| v2 | 2019-07-03 | French | Compare |
| v1 | 2019-07-03 | English | Compare |
Showing 1 to 9 of 9